Onkure Therapeutics (OKUR)CEO sold ~$1.2K
Nicholas A Saccomano, CEO at Onkure Therapeutics, sold ~$1.2K of Onkure Therapeutics shares.
- ~$1.2K
- Approx. value · 358 sh @ $3.33
- 4,198
- Holds after · shares reported
- Traded
- Apr 4, 2025
- Filed
- Apr 8, 2025
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Apr 4, 2025 · this disclosureInsiderCEO sold ~$1.2K of OKUR shares in the open market
What came next
- Apr 4, 2025InsiderCFO sold ~$4.3K of OKUR shares in the open market
- Apr 7, 2025Insider · 2 peopleInsiders: 2 sales (~$6K)
- May 12, 2025Insider10% owner sold ~$48K of OKUR shares in the open market
- May 15, 2025Insider · 2 peopleInsiders: 2 purchases (~$2.6M), 1 sale (~$3.4M)
- Jun 23, 2025Insider · 2 peopleInsiders: 2 sales (~$932)
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Onkure Therapeutics
For Onkure Therapeutics, OQRO holds 1 fund holdings report (13F) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its OKUR page.
Other recent filings by Nicholas A Saccomano, President and CEO
- SEC Form 4 at Onkure Therapeutics (OKUR)Sep 24, 2025
- SEC Form 4 at Onkure Therapeutics (OKUR)Jun 25, 2025
- SEC Form 4 at Onkure Therapeutics (OKUR)Apr 8, 2025
The full history of Nicholas A Saccomano, President and CEO is on the profile page.
How this filing works
Other disclosures at Onkure Therapeutics
- SEC Schedule 13GOct 7, 2026
- SEC Form 4Sep 24, 2025
- SEC Form 4Sep 24, 2025
- SEC Form 4Jun 25, 2025
- SEC Form 4Jun 25, 2025
- SEC Form 4May 19, 2025
Everything OQRO holds on this company is on its OKUR page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO Pro is a paid subscription. You see the price before you pay
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data